Rankings
▼
Calendar
NERV FY 2024 Earnings — Minerva Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena
NERV
Minerva Neurosciences, Inc.
$58M
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$22M
Net Income
$1M
EPS (Diluted)
$0.19
Cash Flow
Operating Cash Flow
-$20M
Free Cash Flow
-$20M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$37M
Total Liabilities
$63M
Stockholders' Equity
-$26M
Cash & Equivalents
$21M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$22M
-$23M
+5.5%
Net Income
$1M
-$30M
+104.8%
← Q4 2023
All Quarters
Q1 2024 →